<DOC>
	<DOCNO>NCT00380874</DOCNO>
	<brief_summary>Prevention treatment severity symptoms chemotherapy-induced peripheral neuropathy .</brief_summary>
	<brief_title>Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer</brief_title>
	<detailed_description>This study terminate July 15 , 2008 . The result interim analysis show conditional power detect difference treatment group insufficient warrant study continuation therefore termination trial recommend . The decision terminate trial base safety concern .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Diagnosis cytological confirm carcinoma Colon Stage III ( Dukes C ) metastatic Colorectal Cancer ( Dukes D ) Independent protocol , patient decide receive standard care treatment cancer oxaliplatin combine 5fluorouracil/folinic acid ( 5FU/FA ) minimum 9 cycle Presence neuropathic pain peripheral polyneuropathy identify cause painful paresthesia include radiotherapyinduced malignant plexopathy , lumbar cervical radiculopathy exist prior baseline Any patient suitable treat either Oxaliplatin and/or 5FU/FA pregabalin accord respective local labeling</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Pain</keyword>
	<keyword>chemotherapy</keyword>
</DOC>